Guardian adds neurological support to HALO claims service

New partnership with Krysalis Consultancy

John Brazier
clock • 2 min read

Challenger insurer Guardian has announced a new partnership with neurological occupational therapy provider, Krysalis Consultancy, for its critical illness claims service.

Guardian has extended the support offered through it HALO claims service to include specialist advice and support to navigate challenges of a neurological diagnosis. The service is aimed at for those living with Parkinson's disease, motor neurone disease, and stroke survivors, or those who have incurred injuries to the brain, spine, or central nervous system, and is available to Guardian critical illness claimants and their families. Krysalis developed its ‘Neuro-Logical' service for the protection industry in response to an increasing gap in the provision of "consistent community-bas...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on Insurer

The COVER Review: Consolidation, healthcare and the FCA Pure Protection Market Study

The COVER Review: Consolidation, healthcare and the FCA Pure Protection Market Study

Week commencing 02 February 2026

COVER
clock 06 February 2026 • 1 min read
Benenden Health sees rise in diagnostics service usage

Benenden Health sees rise in diagnostics service usage

Treatments down 13.1% year-on-year

Jaskeet Briah
clock 06 February 2026 • 2 min read
OneFamily to merge with Scottish Friendly

OneFamily to merge with Scottish Friendly

Combined 2.3m members

Cameron Roberts
clock 04 February 2026 • 2 min read